Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex Open-Label Extension in Multiple Sclerosis
NCT01610713Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- May 2001
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in multiple sclerosis (MS), sponsored by Jazz Pharmaceuticals plc. Started May 2001; status: completed.
02
Drugs
cannabidiol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01610713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01610713.